Bone Biologics Corporation (BBLG) vs Bluejay Diagnostics, Inc. (BJDX)

A side-by-side comparison of Bone Biologics Corporation and Bluejay Diagnostics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Bone Biologics Corporation logo
BBLG
Bone Biologics Corporation
$897948
$0.50HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Bluejay Diagnostics, Inc. logo
BJDX
Bluejay Diagnostics, Inc.
$815044
$0.79HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT

Total return — BBLG vs BJDX

growth of $100 · dividends reinvested · last 5y
BBLG -100.0% (-82.6%/yr)BJDX -100.0% (-91.5%/yr)BBLG compounded faster over this window
Log scale — wide-divergence pair
00001101001kStart $10020222023202420252026$0$0
BBLG BJDX

BBLG vs BJDX: by the numbers

  • •BBLG is the larger company ($897948 vs $815044 market cap).

Metrics side by side

Valuation

MetricBBLGBJDX
P/B ratio0.230.09

Profitability

MetricBBLGBJDX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-73.66%-77.23%
ROIC-78.01%-77.55%

Go deeper

Full BBLG analysisFull BJDX analysisInteractive comparison tool

Dig into the metrics

Bone Biologics ROEBluejay Diagnostics ROEBone Biologics operating marginBluejay Diagnostics operating marginBone Biologics revenue growthBluejay Diagnostics revenue growthBone Biologics free cash flowBluejay Diagnostics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.